abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

هذه الصفحة غير متوفرة باللغة العربية وهي معروضة باللغة English

المقال

17 سبتمبر 2021

الكاتب:
News Beezer

Brazil: Prevent Senior and Hapvida allegedly pressuring doctors to prescribe "covid kit" despite proven ineffectiveness; the companies bought 5 million boxes of chloroquine and ivermectin

"Prevent Senior and Hapvida bought 5 million boxes", 17 September 2021

...[T]wo networks of private hospitals have purchased more than 5 million cases of drugs that have been shown to be ineffective against Covid-19, such as chloroquine, ivermectin and hydroxychloroquine. This shows an unprecedented compilation of Repórter Brasil from internal documents of the health insurance companies that have hospitals: Prevent Senior and Hapvida.

...[T]he prescription continued to appear even after the chloroquine manufacturers published notes that the drug was not recommended for Covid and six months after the WHO declared hydroxychloroquine ineffective. Reports of patients show that drugs from the so-called Covid kit are still being prescribed...

Behind this operator mass distribution was pressure from both leaders for their doctors to prescribe these drugs. There are also complaints from doctors reporting penalties for refusing to set the set, inaction of advice, and the slowness of the relevant public authorities...

At Prevent Senior, the kits were distributed during personal consultation in the operator’s hospital pharmacies or sent to the patients’ homes for telemedical care...

Hapvida and Prevent Senior were included in Covid’s CPI investigations...

Repórter Brasil had access to screenshots of conversations, and in one of them Pedro Benedito Batista Junior, Managing Director of Prevent, who is about to testify at the CPI, urges doctors “not to miss the opportunity to test patients”...

Prevent did not comment on the data or the complaints, simply saying that “it acted within the ethical and legal parameters and, most importantly, with the beneficiaries in mind”. Hapvida has already said that “it respects medical sovereignty and that all treatments are completely autonomous by the professional and are decided in agreement with the patient”...

الجدول الزمني